Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. baxter healthcare sa/
WARNING LETTER
•baxter healthcare sa/•May 12, 2014

baxter healthcare sa/ – FDA Warning Letter, May 12, 2014

Record Details

An FDA inspection from March to May 2014 at Baxter Healthcare of Puerto Rico, a manufacturer of sterile IV sets and parental bags, found its devices adulterated under 21 U.S.C. § 351(h) due to non-compliance with the Quality System Regulation (21 C.F.R. Part 820). The firm's response dated June 3, 2014, was deemed inadequate for several violations. Key violations include: 1) Failure to control production processes to ensure device conformity (21 CFR 820.70(a)). The firm's visual inspection for particulate matter in nutritional containers and empty solution bags was not validated, and employee certification was insufficient. This led to confirmed particulate matter in returned products despite 100% visual inspections. 2) Failure to properly implement CAPA procedures (21 C.F.R. § 820.100(a)). A CAPA investigation into particulate matter complaints was inadequate, untimely, and ineffective, failing to identify the root cause or address the non-validated visual inspections. A 2010 medical assessment indicated a potential for death or serious injury, yet immediate action was not taken, and a field corrective action was improperly dismissed based on inaccurate data and reliance on user detection. Baxter is implementing corrective actions, including using consultants for CAPAs, with some expected by October 2014. However, the firm must address the handling of previously distributed potentially defective products, conduct retrospective assessments, and provide updates on CAPA reviews and a separate "leak defect" investigation. Failure to promptly correct these violations could lead to regulatory actions, impact federal contracts, and hinder device approvals or export certificates. A written response detailing corrective actions and timelines is required within 15 working days.

Company
baxter healthcare sa/
Inspection date
May 12, 2014
Product type
Devices
Office
San Juan District Office
People
  • Enrique Moran
  • Maridalia Torres-Irizarry ( District Director )
View Company Profile

ID · 90cb73a7-b46f-49d6-bd33-813634034215

Violation Codes4
21 U.S.C. 321(h)21 U.S.C. 351(h)21 CFR 820.70(a)21 CFR 820.100(a)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore baxter healthcare sa/
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.